SIGA Technologies, Inc. (SIGA)
NASDAQ: SIGA · Real-Time Price · USD
6.65
-0.23 (-3.34%)
Oct 22, 2024, 4:00 PM EDT - Market closed
SIGA Technologies Revenue
SIGA Technologies had revenue of $21.81M in the quarter ending June 30, 2024, with 271.05% growth. This brings the company's revenue in the last twelve months to $172.96M, up 76.90% year-over-year. In the year 2023, SIGA Technologies had annual revenue of $139.92M with 26.31% growth.
Revenue (ttm)
$172.96M
Revenue Growth
+76.90%
P/S Ratio
2.73
Revenue / Employee
$3,843,484
Employees
45
Market Cap
474.61M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 139.92M | 29.14M | 26.31% |
Dec 31, 2022 | 110.78M | -22.89M | -17.13% |
Dec 31, 2021 | 133.67M | 8.71M | 6.97% |
Dec 31, 2020 | 124.96M | 98.22M | 367.28% |
Dec 31, 2019 | 26.74M | -450.31M | -94.39% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Auna S.A. | 1.10B |
Emergent BioSolutions | 1.10B |
Varex Imaging | 832.70M |
Pacific Biosciences of California | 188.87M |
Talkspace | 172.54M |
Quanterix | 129.33M |
PureTech Health | 468.00K |
Altimmune | 409.00K |
SIGA News
- 23 hours ago - SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies - GlobeNewsWire
- 12 days ago - Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws - GlobeNewsWire
- 13 days ago - SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman - Accesswire
- 14 days ago - Siga Technologies to supply mpox therapy in Morocco - Reuters
- 14 days ago - SIGA Announces Agreement to Supply TPOXX® in Morocco - GlobeNewsWire
- 19 days ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors - Business Wire
- 20 days ago - The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors - Business Wire
- 25 days ago - Wolf Haldenstein Adler Freeman & Herz LLP Announces that it is Investigating SIGA Technologies, Inc. for Potential Violations of Federal Securities Laws - Accesswire